Chemoinformaics analysis of 1,4-Dimethyl benzene
| Molecular Weight | 106.168 | nRot | 0 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 6 |
| Exact Molecular Weight | 106.078 | nRing | 1 |
| Solubility: LogS | -3.011 | nHRing | 0 |
| Solubility: LogP | 3.118 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 20.0279 |
| nHD | 0 | BPOL | 10.0321 |
| QED | 0.476 |
| Synth | 1 |
| Natural Product Likeliness | -0.543 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.263 |
| MDCK | 0.0000243 |
| BBB | 0.93 |
| PPB | 0.889232 |
| VDSS | 2.438 |
| FU | 0.116739 |
| CYP1A2-inh | 0.941 |
| CYP1A2-sub | 0.943 |
| CYP2c19-inh | 0.891 |
| CYP2c19-sub | 0.879 |
| CYP2c9-inh | 0.351 |
| CYP2c9-sub | 0.676 |
| CYP2d6-inh | 0.168 |
| CYP2d6-sub | 0.906 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.576 |
| CL | 11.126 |
| T12 | 0.632 |
| hERG | 0.057 |
| Ames | 0.033 |
| ROA | 0.058 |
| SkinSen | 0.31 |
| Carcinogencity | 0.59 |
| EI | 0.996 |
| Respiratory | 0.056 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.915072 |